glp-1 reimbursement news David Graziano GLP-1 Receptor Agonist Shortage: Challenges
Description
See your protein add up, even on the days you can barely eat
Clinical trial data have produced mixed findings that require careful interpretation
10.2337/diabetes.49.11.1751 Diabetes 16 HolstJ
The needle went deeper than expected
Oral Wegovy could enter India in 6 to 9 months Oral format materially expands addressable patients Especially relevant in India where injections face resistance 4 Cold Chain Advantage - Underrated Factor Oral GLP-1 does not require refrigeration Easier distribution Deeper semi-urban & rural penetration This alone expands the market size materially
Kidney Int 2022;102:97489
